AAO 2022: Dr. Kim Presents Phase 2 SC Safety Belzupacap Sarotalocan Data

A Phase 2 Trial of Belzupacap Sarotalocan (AU-011), a First-in-Class Targeted Therapy for Choroidal Melanoma via Suprachoroidal Administration